MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, FBIOP made $16,038K in revenue. $108,365K in net income. Net profit margin of 675.68%.

Income Overview

Revenue
$16,038K
Net Income
$108,365K
Net Profit Margin
675.68%
EPS
$2.82
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product revenue, net
    • Fortress Biotech Inc
    • Journey
Revenue Breakdown
    • Journey
    • Fortress Biotech Inc
Revenue Breakdown
    • Revenue from contract with custo...
    • Revenue from contract with custo...
    • Revenue from contract with custo...
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenue
16,038 12,196* 17,631 16,413
Cost of goods - (excluding amortization of acquired intangible assets)
6,218 4,883* 5,755 4,939
Amortization of acquired intangible assets
1,126 1,066* 1,064 1,064
Research and development
540 -600* 208 8,126
Selling, general and administrative
15,893 12,142* 17,415 38,757
Total operating expenses
23,777 17,491* 24,442 52,886
Loss from operations
-7,739 -5,295* -6,811 -36,473
Interest income
570 448* 736 622
Loss from deconsolidation of subsidiary
--16,861* -27,127
Interest expense and financing fee
3,368 2,216* 2,742 2,518
Gain on sale of priority review voucher, net of expenses
158,873 ---
Change in fair value of partner company derivative liability
-7,085 ---
Loss (gain) on common stock warrant liabilities
1 130* -2 -350
Other income (expense)
1,042 -8,837* 17,672 -62
Total other income (expense)
150,033 -27,336* 15,664 24,819
Income (loss) before income tax expense
142,294 -32,631* 8,853 -
Income tax expense
5,132 -698* 26 -
Net income (loss)
137,162 -31,933* 8,827 -11,654
Attributable to non-controlling interests
26,789 -3,485* 2,977 -27,140
Net income (gain) attributable to fortress
110,373 -28,448* 5,850 15,486
Preferred a dividends declared and paid and/or cumulated, and fortress' share of subsidiary deemed dividends
2,008 2,175* 2,174 -
Net income (loss) attributable to common stockholders
108,365 -30,623 3,675 -
Basic EPS
3.44 -1.035 0.13 0.5
Diluted EPS
2.82 -1.474 0.11 0.45
Basic Average Shares
31,540,595 29,581,813 27,244,474 26,879,380
Diluted Average Shares
38,412,716 20,780,524 33,100,961 29,824,182
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Gain on sale ofpriority review voucher,...$158,873K Other income(expense)$1,042K Interest income$570K Loss (gain) on commonstock warrant...$1K Fortress Biotech Inc$77K Journey$40K Total other income(expense)$150,033K Change in fair value ofpartner company...-$7,085K Interest expense andfinancing fee$3,368K Product revenue, net$15,921K Other revenue$117K Income (loss) beforeincome tax expense$142,294K Loss from operations-$7,739K Net revenue$16,038K Net income (loss)$137,162K Income tax expense$5,132K Total operatingexpenses$23,777K Net income (gain)attributable to fortress$110,373K Attributable tonon-controlling interests$26,789K Selling, general andadministrative$15,893K Cost of goods -(excluding amortization of...$6,218K Amortization of acquiredintangible assets$1,126K Research and development$540K Net income (loss)attributable to common...$108,365K Preferred a dividendsdeclared and paid and/or...$2,008K

Fortress Biotech, Inc. (FBIOP)

Fortress Biotech, Inc. (FBIOP)